Scheduled Maintenance
We have scheduled some maintenance on Saturday 4th of May 2024 starting from 10AM CEST and could last for 2 hours. During this maintenance we are expecting our website to be unavailable or not fully functional.
Top movers in Thursday's session
By Mill Chart
Last update: Apr 4, 2024
What's going on in today's session
Top gainers
| Ticker | Change | Comment |
|---|---|---|
| STKH | 863.0% | Exciting news for STEAKHOLDER FOODS LTD (NASDAQ:STKH) as its stock price surged 863.0% to $5.2 during Thursday's session. In the last 6 months the share price dropped with 34.19%. |
| TCBP | 43.85% | TC BIOPHARM HOLDINGS PLC-ADR (NASDAQ:TCBP) experienced a significant 43.85% increase, reaching $1.87 during Thursday's session. In the last 3 months the stock lost 41.44%. |
| HUBC | 39.07% | Investors witnessed a remarkable 39.07% rise in HUB CYBER SECURITY LTD's (NASDAQ:HUBC) shares, which climbed to $1.0 during Thursday's session. A press release (HUB Cyber Security Acquires QPoint Technologies, Advancing its Plans for a Secured Data Fabric Ecosystem) was released earlier today. |
| EIGR | 35.15% | Investors celebrated as EIGER BIOPHARMACEUTICALS INC (NASDAQ:EIGR) experienced a 35.15% rise in its shares, closing at $2.23 during Thursday's session. In the last month the stock lost 76.26%. |
| NKTR | 31.25% | Investors witnessed a remarkable 31.25% rise in NEKTAR THERAPEUTICS's (NASDAQ:NKTR) shares, which climbed to $1.36 during Thursday's session. Shareholders saw the stock price going 94.28% higher in the past 3 months. |
| HWH | 31.17% | HWH INTERNATIONAL INC's (NASDAQ:HWH) stock price displayed strong growth, advancing 31.17% and reaching $2.06 during Thursday's session. In the last month the share price increased with 57.0%. |
| MGNX | 30.65% | MACROGENICS INC's (NASDAQ:MGNX) stock price is advancing with 30.65% to a price of $17.86. The stock is trading 33.77% lower than a month ago. |
| EJH | 26.14% | With a 26.14% surge, E-HOME HOUSEHOLD SERVICE's (NASDAQ:EJH) stock price reached $2.22 during Thursday's session, signaling positive momentum. Shareholders saw the stock price going 51.71% lower in the past 3 months. |
| DOGZ | 24.75% | DOGNESS INTERNATIONAL CORP-A (NASDAQ:DOGZ) experienced a significant 24.75% increase, reaching $10.13 during Thursday's session. Shareholders saw the stock price going 24.92% higher in the past month. |
| IGC | 23.44% | IGC PHARMA INC's (NYSEARCA:IGC) shares rose 23.44% to $0.79. In the last month the share price increased with 90.99%. |
For the full top gainers list go to our top gainers page.
Today's top losers
| Ticker | Change | Comment |
|---|---|---|
| EFTR | -78.14% | EFFECTOR THERAPEUTICS INC's (NASDAQ:EFTR) shares fell 78.14% to $3.6. Earlier today the company had a press release: eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer. |
| VIEW | -34.51% | VIEW INC's (NASDAQ:VIEW) stock price decreased by 34.51% to $0.33. Two days ago the company had a press release: View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company. |
| JZXN | -32.9% | JIUZI HOLDINGS INC's (NASDAQ:JZXN) stock price is declining with 32.9% to a price of $1.0. The stock is trading 88.61% higher than 3 months ago. |
| CASA | -29.27% | CASA SYSTEMS INC's (NASDAQ:CASA) shares fell 29.27% to $0.04. Yesterday the company had a press release: Casa Systems Initiates Court-Supervised Chapter 11 Sale Process for Businesses. |
| AXTI | -25.96% | AXT INC's (NASDAQ:AXTI) shares fell 25.96% to $3.67 during Thursday's session. In the last 3 months the share price increased with 98.0%. |
| ACHL | -25.1% | Investors witnessed a 25.1% decrease in ACHILLES THERAPEUTICS PL-ADR's (NASDAQ:ACHL) stock price, which closed at $0.9 during Thursday's session. A press release (Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights) was released yesterday. |
| NOTV | -22.94% | There was a downturn in INOTIV INC's (NASDAQ:NOTV) shares, as they experienced a 22.94% decline, closing at $7.29 during Thursday's session. In the last 3 months the share price increased with 124.0%. |
| SLNA | -22.7% | There was a downturn in SELINA HOSPITALITY PLC's (NASDAQ:SLNA) shares, as they experienced a 22.7% decline, closing at $0.08 during Thursday's session. In the last month the stock lost 63.32%. |
| AISPW | -20.0% | Investors witnessed a 20.0% decrease in AIRSHIP AI HOLDINGS INC-CW28's (NASDAQ:AISPW) stock price, which closed at $0.8 during Thursday's session. In the last month the stock gained 203.0%. |
| LW | -19.38% | During Thursday's session, LAMB WESTON HOLDINGS INC's (NYSE:LW) shares took a tumble, falling 19.38% to $81.52. yesterday the company released their earnings. A press release (Lamb Weston Reports Fiscal Third Quarter 2024 Results; Updates Fiscal Year 2024 Outlook) was released earlier today. |
Our top losers page will show you the full list.
ACHILLES THERAPEUTICS PL-ADR
NASDAQ:ACHL (5/3/2024, 7:00:00 PM)
After market: 0.81 +0.01 (+0.78%)0.8037
+0.02 (+3.04%)
ACHL News
a month ago - InvestorPlaceACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023ACHL stock results show that Achilles Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
a month ago - BusinessInsiderACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Achilles Therapeutics (NASDAQ:ACHL) just reported results for the fourth quarte...
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayWe're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning!
a month ago - Achilles Therapeutics PLCAchilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights– Provided interim Phase I/IIa update on clonal neoantigen reactive T cells in advanced NSCLC and melanoma – – Improved VELOS™ manufacturing process...
a month ago - Achilles Therapeutics PLCAchilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning– Improved VELOS™ manufacturing process delivering higher cNeT doses – – Protocols updated to evaluate the benefit of enhanced host conditioning, with...
3 months ago - Achilles Therapeutics PLCAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 ConferenceLONDON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered...
5 months ago - Achilles Therapeutics PLCAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity PredictionNewly developed computational tools and large datasets with low bias will lead to robust neoantigen prediction and improved personalized cancer therapies
Newly developed computational tools and large datasets with low bias will lead to robust neoantigen prediction and improved personalized cancer therapies...
6 months ago - Achilles Therapeutics PLCAchilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
